Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection

Eur Respir J. 2013 Aug;42(2):547-50. doi: 10.1183/09031936.00064713.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibiotics, Antitubercular / administration & dosage
  • Antitubercular Agents / administration & dosage
  • Apolipoproteins A / metabolism
  • Apolipoproteins B / metabolism
  • Biomarkers / blood*
  • Female
  • Humans
  • Isoniazid / administration & dosage
  • Latent Tuberculosis / blood*
  • Latent Tuberculosis / diagnosis
  • Lipid Metabolism
  • Lipids / blood*
  • Male
  • Middle Aged
  • Rifampin / administration & dosage
  • Young Adult

Substances

  • Antibiotics, Antitubercular
  • Antitubercular Agents
  • Apolipoproteins A
  • Apolipoproteins B
  • Biomarkers
  • Lipids
  • Isoniazid
  • Rifampin